Publication Name	World Journal of Gastroenterology
Manuscript ID	79878
Country	Egypt

Received	2022-09-10 10:45
Peer-Review Started	2022-09-10 10:47
To Make the First Decision
Return for Revision	2022-11-17 04:46
Revised	2022-12-29 10:59
Second Decision	2023-02-09 03:00
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-02-14 22:38
Articles in Press	2023-02-14 22:38
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-02-15 07:58
Publish the Manuscript Online	2023-02-21 06:19

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes
Manuscript Source	Invited Manuscript
All Author List	Zeinab Nabil Ahmed Said, Safinaz Adel El Habashy and Samy Zaky
Funding Agency and Grant Number
Corresponding Author	Zeinab Nabil Ahmed Said, PhD, Additional Professor, Department of Medical Microbiology and Immunology, Faculty of Medicine (For Girls), Al-Azhar University, Elshenawy St., Cairo 11754, Nasr City, Egypt. znabil58@yahoo.com
Key Words	COVID-19; SARS-CoV-2; Liver injury; Transaminases; Hyperbilirubinemia; Pathophysiology
Core Tip	Recent evidence confirmed coronavirus disease 2019-induced liver function test abnormalities in patients with or without preexisting liver injury. Understanding the mechanism and recognizing the clinical picture, as well as identifying the risk factors for developing such abnormalities, will pave the way for early diagnosis and better management of such cases.
Publish Date	2023-02-21 06:19
Citation	Said ZNA, El Habashy SA, Zaky S, ESCMID Study Group for Viral Hepatitis. COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes. World J Gastroenterol 2023; 29(7): 1123-1130
URL	https://www.wjgnet.com/1007-9327/full/v29/i7/1123.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i7.1123

Full Article (PDF)	WJG-29-1123.pdf
Full Article (Word)	WJG-29-1123.docx
Manuscript File	79878_Auto_Edited-LM.docx
Answering Reviewers	79878-Answering reviewers.pdf
Audio Core Tip	79878-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	79878-Conflict-of-interest statement.pdf
Copyright License Agreement	79878-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	79878-Language certificate.pdf
Peer-review Report	79878-Peer-review(s).pdf
Scientific Misconduct Check	79878-Bing-Fan JR-2.png
Scientific Editor Work List	79878-Scientific editor work list.pdf
CrossCheck Report	79878-CrossCheck report.pdf
CrossCheck Report	79878-CrossCheck.png